Axios Alerts: CDC panel backs Pfizer booster for 12- to 17-year olds

Alerts   Axios    CDC panel backs Pfizer boosters for 12- to 17-year-olds Why it matters: The CDC director is expected to back the panel's recommendation, expanding the number of children eligible for boosters amid a surge of COVID-19 cases.   Download the Axios App Follow Axios on Social Media Contact Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201   You received this email because you signed up for news alerts from Axios. Change your preferences or unsubscribe here.